Abstract:Objective To summarize the clinical features of 22 probands diagnosed with congenital muscular dystrophy (CMD),and to provide genetic counseling and prenatal diagnosis for 23 fetuses of these pedigrees.Methods Data of 22 CMD patients who were treated in the Pediatric Department of Peking University First Hospital during October 2006 to March 2016 were analyzed.Informed written consents for participation in this study were obtained from the parents or guardians.Prenatal diagnosis was performed using DNA samples extracted from fetal villus cells of 12 cases at 11-13 gestational weeks and amniotic fluid of 11 cases at 18-22 gestational weeks.Direct DNA sequencing by polymerase chain reaction (PCR) and multiplex ligation-dependent probe amplification (MLPA) were used to detect CMD-related gene mutations.Linkage analysis of short tandem repeats (STRs) was used to identify maternal blood contamination and biological parents.Results Thirteen out of the 22 probands with CMD were diagnosed with congenital muscular dystrophy type 1 A (MDC1A),and all of them carried compound heterozygous mutations in LAMA2 gene.Prenatal diagnosis of 13 fetuses from these pedigrees found that four fetuses were wild-type,seven were heterozygotes and two carried the same mutations as their proband.Three probands with LMNA-related congenital muscular dystrophy (L-CMD) carried de novo mutations in LMNA gene.In these pedigrees,two fetuses were wild-type and one whose mother was mosaicism carried the same mutations as the proband.One proband with Ullrich congenital muscular dystrophy carried compound heterozygous mutations in COL6A2 gene and the fetus of the same pedigree was wild-type.Five probands were diagnosed with α-dystroglycanopathies.And among them,two cases of muscle-eye-brain disease (MEB) carried compound heterozygous mutations in POMGnT1 gene and the fetuses of the two peidgrees were heterozygotes;one case of congenital muscular dystrophy type 1C (MDC1C) had compound heterozygous mutations in FKRP gene and the fetus carried the same mutations;one patient diagnosed with POMGnT1-related congenital muscular dystrophy with mental retardation (CMD-MR) carried compound heterozygous mutations in POMGnT1 gene,and the fetus was positive for the same mutations;one proband with POMT1-related CMD-MR was positive for compound heterozygous mutations in POMT1 gene and the results of prenatal diagnosis for two fetuses of this pedigree showed that the first fetus had the same mutations as the proband,while the second was heterozygote.Conclusions No effective therapeutic method is available for CMD.Therefore,accurate genetic counseling and prenatal diagnosis are necessary to prevent CMD child from birth.

Diagnosis and therapy of congenital myopathies

Congenital myopathies: pathophysiological mechanisms and promising therapies

[Progress of Clinical and Genetic Research on Distal Hereditary Motor Neuropathy].

Clinical and Genetic Features of Infancy-Onset Congenital Myopathies from a Chinese Paediatric Centre

Genetic and Clinical Advances of Congenital Muscular Dystrophy.

Congenital Myopathy with Type 1 Fiber Predominance in Two Children

Myotonic Disorders in Childhood: Diagnosis and Treatment

Congenital Myasthenic Syndrome in China: Genetic and Myopathological Characterization

Clinical Characteristics of Myotonia Congenita in China - Literature Analysis of the Past 30 Years

Clinical and Pathological Features of Muscular Dystrophy Congenital 1A

Congenital Myasthenic Syndromes: a Clinical and Treatment Approach

Congenital myotonic dystrophy; a report on thirteen cases and a review of the literature

Clinical Festures and CLCN1 Gene Mutation Screen on a Myotonia Congenital Kindred

Clincal and Pathological Studies on Myotonic Dystrophy

Clinical manifestations and prenatal diagnosis of congenital muscular dystrophy

Presentation, clinical course, and outcome of the congenital form of myotonic dystrophy

Advances in Diagnosis and Treatment of Limb-Girdle Muscular Dystrophy

Clinical Reasoning: A 19-Month-Old Girl With Infantile-Onset Myopathy and White Matter Changes

The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment

Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review

CLINICAL AND IMMUNOHISTOCHEMISTRY FEATURES IN 8 CASES OF CONGENITAL MUSCULAR DYSTROPHY